Tirzepatide (5 mg, 10 mg)
Price range: $99.95 through $179.99
Dual GIP/GLP-1 receptor agonist for metabolic and endocrine research
 Overview [research use only]
Tirzepatide is a synthetic 39âamino acid peptide designed as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. This combined activity allows modulation of insulin secretion, glucose metabolism, appetite regulation, and energy balance. Preclinical and clinical studies highlight its potential in obesity and type 2 diabetes models, showing significant improvements in glycemic control, lipid metabolism, and body weight reduction. Its dual incretin activity makes it a unique and powerful tool in metabolic research.
Specifications
- Synonyms: Tirzepatide, LY3298176
- Molecular formula: C225H348N48O68
- Molecular weight: ~ 4813 g/mol
- CAS number: 2023788-19-2
- Appearance: White to off-white lyophilized (freeze-dried) powder
 Packaging and Storage
Supplied as a lyophilized powder in vials (5 mg and 10 mg). Store at â20 °C for long-term stability, protected from light and moisture. After reconstitution in sterile water or buffer, aliquot and store at 2â8 °C for short-term use or â20 °C for extended preservation. Avoid multiple freezeâthaw cycles.
Safety and Legal
For laboratory research use only. Not for human or veterinary use. Not a drug, food, or cosmetic
| Weight | .5 lbs |
|---|---|
| Dimensions | .63 × .63 × 1.4 in |
| Size |
10 mg ,5 mg |
Related products
Semaglutide (5 mg, 10 mg)
In stock
TB-500 (5 mg, 10 mg)
In stock
